Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Tetraphase Pharmaceuticals logo — Fighting against antimicrobial resistance is at the core of...

Tetraphase Pharmaceuticals

Fighting against antimicrobial resistance is at the core of our technology and our people.

Founded 2006 United States Watertown, United States 14 employees Grant Total: $99.04M Biopharma, Biotechnology +1

General Information

Company Name Tetraphase Pharmaceuticals
Founded Year 2006
Location United States Watertown, United States
Founders / Decision Makers
Team member
Employees 14
Industries Biopharma, Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Tetraphase Pharmaceuticals. To contact Tetraphase Pharmaceuticals, visit tphase.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tetraphase Pharmaceuticals compare?

A PDF of Tetraphase Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tetraphase Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals is a biopharmaceutical company founded in 2006 with the slogan, "Fighting against antimicrobial resistance is at the core of our technology and our people." The company is dedicated to combating antibiotic resistance, which is described as one of the most significant threats to humanity. According to The Review on Antimicrobial Resistance, by 2050, antimicrobial resistance is projected to kill more people than cancer and diabetes combined. The company's lead product, XERAVA, is approved for the treatment of complicated intra-abdominal infections (cIAI). Tetraphase is driven by a well-defined mission targeting antibiotic resistance, with their recent investment being a $4.00M grant from CARB-X in April 2017. Tetraphase has the focus and flexibility to explore a broad range of antibiotic solutions. With its commitment to developing new antibiotics that can overcome the challenges of drug-resistant bacteria, the company aims to ensure the availability of effective treatments in the future. Their dedication to making novel antibiotics accessible to all patients in need reflects in their passion for combating antibiotic resistance.

Business keywords: antimicrobial resistance, antibiotic, novel antibiotics, pharmaceuticals, drug-resistant bacteria, cIAI treatment, XERAVA, drug development, public health, infectious diseases, health innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $4.00M 1
CARB-X
CARB-X
01 Apr 2017
Venture Round Undisclosed -
01 Mar 2013
Private Equity Round Undisclosed 1
CB Health Ventures
01 Jan 2012
Series C $45.00M 6
F-Prime Capital Skyline Ventures Excel Venture Management
F-Prime Capital, Skyline Ventures +4
01 Jun 2010
Series B $25.00M 5
F-Prime Capital Skyline Ventures Flagship Pioneering
F-Prime Capital, Skyline Ventures +3
22 Sep 2009
Series A $15.00M 5
Skyline Ventures Flagship Pioneering CMEA Capital
Skyline Ventures, Flagship Pioneering +3
07 Aug 2008
Series A $10.04M 5
F-Prime Capital Skyline Ventures Flagship Pioneering
F-Prime Capital, Skyline Ventures +3
01 Nov 2006

Tetraphase Pharmaceuticals Alternatives & Competitors

View All Alternatives
Tetraphase Pharmaceuticals vs
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. United Kingdom

Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance with engine...

Venture round
10 employees
Biopharma, Biotechnology
Tetraphase Pharmaceuticals vs
Curza
Curza

Small molecule therapeutics R&D company focused on developing new drugs to combat antibiotic resista...

Venture round
17 employees
Biotechnology, Health Care
Tetraphase Pharmaceuticals vs
Qpex Biopharma
Qpex Biopharma United States

Focusing on Resistance in Antibiotic Development

Grant
29 employees
Biotechnology, Health Care
Compare Tetraphase Pharmaceuticals vs Qpex Biopharma
Also compare with: Tetraphase Pharmaceuticals vs Melinta Therapeutics Melinta Therapeutics Tetraphase Pharmaceuticals vs EMPE Diagnostics EMPE Diagnostics View all alternatives

FAQ About Tetraphase Pharmaceuticals

Fighting against antimicrobial resistance is at the core of our technology and our people.
Tetraphase Pharmaceuticals was founded in 2006.
Tetraphase Pharmaceuticals is headquartered in Watertown, United States.
Tetraphase Pharmaceuticals operates in Biopharma, Biotechnology and Health Care. Its work centres on antimicrobial resistance, antibiotic, novel antibiotics and pharmaceuticals.
Tetraphase Pharmaceuticals has approximately 14 employees.
Tetraphase Pharmaceuticals has completed 7 funding rounds, raising a total of $99.04M. The latest funding stage is Grant.
Top alternatives and competitors to Tetraphase Pharmaceuticals include Phico Therapeutics Ltd., Curza, Qpex Biopharma, Melinta Therapeutics, Synereca Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tetraphase Pharmaceuticals and Phico Therapeutics Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tetraphase Pharmaceuticals, https://bouncewatch.com/company/tetraphase-pharmaceuticals, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout